|
|
|
|
|
|
by HalcyonMuse
6148 days ago
|
|
|
The article in the comment you replied on has a solid theory: it's hard to patent bacteriophages in their natural state, and tailoring bacteriophages to a specific person presents difficulties with the FDA. Therefore, obtaining profit through these methods is difficult. |
|
|